Top compounds associated with response to CH17-270A2.2


Feature Type Standardized
Nominal ANOVA
mRNA canertinib CTRPv2 pan-cancer AAC -0.18 5e-06
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.17 6e-06
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.17 1e-05
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 3e-05
mRNA neratinib CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0003
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.15 0.0005
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.14 0.0005
Download CSV